June 30th 2025
Pediatricians offer anecdotal evidence in ACIP deliberations as vaccine skepticism grows under RFK Jr.
June 27th 2025
Vaccines become center of the medical world as ACIP meets to advise CDC.
June 26th 2025
RFK-appointed panel approves vaccines for babies, youths and adults in its first official meeting.
Vaccine supporters say science is on their side, but others want more research and better guidance on getting inoculated against illness.
June 25th 2025
Medical organizations publish open letter to American public as new ACIP panel meets with new members.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
HHS to make COVID-19 vaccines more available to older adults, disabled people
Agencies will provide about $100 million in grants to aging and disability networks across the country.
AstraZeneca releases updated COVID-19 vaccine data
The updated data was released after U.S. regulators questioned a release earlier this week.
Half opposed COVID-19 vaccine in late 2020
An online survey conducted in late-2020 shows what drove vaccine hesitancy.
Updated: AstraZeneca COVID-19 vaccine candidate proves effective in Phase III trial
The vaccine candidate met the primary efficacy endpoint in preventing COVID-19 in an interim analysis.
CMS increasing payment for COVID-19 vaccinations
The national average payment rate will increase by about $12 for administering each dose of the vaccines.
Study: Physician consultation leads to pandemic vaccination
A look at data from the swine flu pandemic shows that physicians who talk vaccination with their doctor often get the shot.
Five takeaways from Biden’s big COVID-19 week
President Joe R. Biden marked the anniversary of the onset of the COVID-19 coronavirus pandemic with a flood of action.
BREAKING: Biden announces purchase of 100 million Johnson & Johnson COVID-19 vaccine doses
The new doses will spring from the production partnership of Johnson & Johnson and Merck.
CDC releases post-vaccination COVID-19 recommendations
Those who have been fully vaccinated can safely visit other vaccinated people and small groups of those who have yet to get the jab.
Building confidence in vaccines: A free MJH Life Sciences COVID-19 Coalition webinar
The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.
Deal reportedly struck for Merck to help manufacture Johnson & Johnson COVID-19 vaccine
Multiple news organizations report that the White House has brokered the unusual deal.
Free MJH Life Sciences COVID-19 Coalition webinar to focus on vaccines
FDA grants Johnson & Johnson COVID-19 vaccine EUA
The single-dose vaccine is the third granted emergency use authorization in an effort to end the COVID-19 coronavirus pandemic.
Coronavirus: Johnson & Johnson vaccine shows high effectiveness
Documents released by the FDA before they consider an EUA for the single-dose vaccine show that it is effective against COVID-19.
Coronavirus: Pfizer to ship 13 million vaccine doses a week to U.S.
The drug maker expects to deliver 120 million doses of its COVID-19 vaccine by the end of March.
Free COVID-19 law, ethics webinar tomorrow
The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar tomorrow at 6 p.m. EST.
Poll: Americans expect COVID-19 disruptions to continue well into 2021
More than half of Americans expect disruptions to persist past the middle of this year, a jump from late-December’s responses.
Free webinar to focus on law, ethics of COVID-19 vaccinations
The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar at 6 p.m. EST, Feb. 24.
ACP supports legislation increasing healthcare access, combatting COVID-19 pandemic
In a pair of letters to congressional committees, the organization extolls the benefits of provisions in upcoming COVID relief legislation.
Coronavirus: Primary care physicians taking part in vaccine effort, many await supply
Primary care physicians are getting involved with the vaccination effort, but only 19 percent say they’re currently administering the shots.
Health care associations produce pro-COVID vaccine PSA
The public service announcement urges Americans to be vaccinated against COVID-19.
Novavax begins rolling review of COVID-19 vaccine candidate
The drug maker has started reviews with regulatory agencies across the world.
Coronavirus: Johnson & Johnson seeking vaccine candidate EUA
The company plans to supply the federal government with 100 million doses in the first half of 2021.
Q&A: Involving local practices in COVID-19 vaccinations
Anders Gilberg, senior vice president of government affairs for MGMA, discusses a recent survey and how his organization is reaching out to the White House.
Coronavirus: AstraZeneca Oxford vaccine candidate shows promise in trials
Survey shows generational vaccine attitudes
With the holidays upon us, concern continue to increase about the combination of influenza and COVID-19.
Coronavirus: vaccine candidates show promise in trials
New COVID-19 coronavirus vaccine candidates from Johnson & Johnson and Novavax have shown high efficacy on some variants of the disease.
Coronavirus: Demand grows for vaccine
A survey found more Americans looking to get vaccinated as soon as possible versus in December.
Coronavirus: Moderna seeks to boost vaccine immunity to virus variants
The drug maker says their vaccine is still effective against emerging COVID-19 variants, but it still wants to test.
MGMA Survey: Physician practices left out of COVID-19 vaccine rollout
The survey showed that a vast majority of independent practices actively seeking COVID-19 vaccines haven’t received any doses.